U.S. opens tariff probe targeting Germany’s drug pricing policies
AI Summary
The U.S. Trade Representative initiated a tariff probe into Germany's drug pricing policies, criticizing Germany's plan to reduce medicine spending as a regression. This investigation could impact trade relations concerning pharmaceutical products between the two countries.
U.S. Trade Representative Jamieson Greer said Germany's proposal to reduce spending on medicines was "a serious step backwards."
Politics Markets Commodities U.S. Germany tariff probe drug pricing pharmaceutical spending trade relations